Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01460147 · ClinicalTrials.gov registry record · NA
Osteoporosis and MRI Study in Hemophilia
A NA study, sponsored by Baxalta now part of Shire.
- Terminated
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT01460147: Clinical Trial NA study, sponsored by Baxalta now part of Shire.
NCT01460147 is a NA study that was terminated before completion, run by Baxalta now part of Shire. The registered enrollment target is 3 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01460147, a NA study, was terminated before completion, sponsored by Baxalta now part of Shire.
- TERMINATED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate bone mineral density in adult subjects with hemophilia versus a comparator population without hemophilia (non-hemophilia age- and gender-matched database) by using the following diagnostic means: dual-energy X-ray absorptiometry (DXA) scanning, clinical scales, quality of life (QOL) scales and biomarkers. In addition to this osteoporosis study, hemophilic arthropathy of the knee with respect to loss of knee cartilage will also be explored by using magnetic resonance imaging (MRI substudy). No investigational product will be dispensed.
Interventions
- OTHER DXA scan + MRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2011-10-30 |
| Est. Completion | 2012-04-13 |
| Phase | NA |
Why NCT01460147 stopped before completion
NCT01460147 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which DXA scan + MRI is the first listed.
NCT01460147 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01460147 about?
NCT01460147 is a clinical study titled "Osteoporosis and MRI Study in Hemophilia". The purpose of this study is to evaluate bone mineral density in adult subjects with hemophilia versus a comparator population without hemophilia (non-hemophilia age- and gender-matched database) by using the following diagnostic means: dual-energy X-ray absorptiometry (DXA) scanning, clinical scale...
What is the current status of trial NCT01460147?
This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2011-10-30. Estimated completion is 2012-04-13.
What interventions are being tested in trial NCT01460147?
The interventions under investigation include: DXA scan + MRI (OTHER).
Who is sponsoring clinical trial NCT01460147?
This trial is sponsored by Baxalta now part of Shire, which has 74 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01460147's enrollment target sits among peer trials
3 1996th of 2000 higher than 4 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI